相似文献
1
Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India.
Antimicrob Agents Chemother. 2011 Jan;55(1):447-8. doi: 10.1128/AAC.01305-10. Epub 2010 Oct 25.
2
Detection of KPC-2-producing Citrobacter freundii isolates in Spain.
J Antimicrob Chemother. 2010 Dec;65(12):2695-7. doi: 10.1093/jac/dkq352. Epub 2010 Sep 16.
3
Aztreonam-Avibactam Combination Restores Susceptibility of Aztreonam in Dual-Carbapenemase-Producing Enterobacteriaceae.
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00414-18. Print 2018 Aug.
4
Coexistence of NDM-1-producing Escherichia coli and Citrobacter freundii in the same patient.
J Glob Antimicrob Resist. 2018 Dec;15:79-81. doi: 10.1016/j.jgar.2018.04.013. Epub 2018 May 1.
5
Complete sequence of the IncT-type plasmid pT-OXA-181 carrying the blaOXA-181 carbapenemase gene from Citrobacter freundii.
Antimicrob Agents Chemother. 2013 Apr;57(4):1965-7. doi: 10.1128/AAC.01297-12. Epub 2013 Jan 28.
6
First identification of VIM-1-producing Citrobacter freundii in Greece.
Int J Antimicrob Agents. 2008 Nov;32(5):460-1. doi: 10.1016/j.ijantimicag.2008.05.008. Epub 2008 Aug 19.
7
Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases.
Diagn Microbiol Infect Dis. 2005 Aug;52(4):331-6. doi: 10.1016/j.diagmicrobio.2005.04.012.
8
Circulation of -Carrying IncX3 Plasmids among Citrobacter freundii Isolates in an Italian Hospital.
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00505-17. Print 2017 Aug.
9
Multidrug-resistant Citrobacter freundii ST139 co-producing NDM-1 and CMY-152 from China.
Sci Rep. 2018 Jul 13;8(1):10653. doi: 10.1038/s41598-018-28879-9.
10
Companion animals: a relevant source of extended-spectrum β-lactamase-producing fluoroquinolone-resistant Citrobacter freundii.
Int J Antimicrob Agents. 2011 Jan;37(1):86-7. doi: 10.1016/j.ijantimicag.2010.09.007. Epub 2010 Nov 11.
引用本文的文献
1
Presence of Coliforms and Reduced Water Quality in the Second Biggest Reservoir in São Paulo, Brazil.
Life (Basel). 2025 Apr 30;15(5):729. doi: 10.3390/life15050729.
2
A brief insight into species - a growing threat to public health.
Front Antibiot. 2023 Dec 5;2:1276982. doi: 10.3389/frabi.2023.1276982. eCollection 2023.
3
Carbapenem-resistant Citrobacter amalonaticus and VRE bacteraemia in an immunocompetent patient after a urological Rezum procedure.
Access Microbiol. 2024 Oct 10;6(10). doi: 10.1099/acmi.0.000852.v4. eCollection 2024.
4
Quercetin-Derived Platinum Nanomaterials Influence Particle Stability, Catalytic, and Antimicrobial Performance.
ACS Omega. 2024 Aug 30;9(37):38557-38568. doi: 10.1021/acsomega.4c02948. eCollection 2024 Sep 17.
5
A review of bacterial disease outbreaks in rainbow trout (Oncorhynchus mykiss) reported from 2010 to 2022.
J Fish Dis. 2023 Nov 15. doi: 10.1111/jfd.13886.
6
NDM-beta-lactamase-1: Where do we stand?
Indian J Med Res. 2022 Feb;155(2):243-252. doi: 10.4103/ijmr.IJMR_685_19.
7
Carbapenem Resistance among Marine Bacteria-An Emerging Threat to the Global Health Sector.
Microorganisms. 2021 Oct 14;9(10):2147. doi: 10.3390/microorganisms9102147.
8
Characterization of Plasmid Co-Harboring NDM-1 and SHV-12 from a Multidrug-Resistant Strain ZT01-0079 in China.
Infect Drug Resist. 2021 Mar 9;14:947-952. doi: 10.2147/IDR.S301736. eCollection 2021.
9
sp. nov. Isolated from Kidney of Diseased Rainbow Trout ().
Microorganisms. 2021 Jan 28;9(2):275. doi: 10.3390/microorganisms9020275.
10
Diversity and Genetic Basis for Carbapenem Resistance in a Coastal Marine Environment.
Appl Environ Microbiol. 2020 May 5;86(10). doi: 10.1128/AEM.02939-19.
本文引用的文献
1
Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia.
Antimicrob Agents Chemother. 2010 Nov;54(11):4914-6. doi: 10.1128/AAC.00878-10. Epub 2010 Sep 7.
2
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.
Lancet Infect Dis. 2010 Sep;10(9):597-602. doi: 10.1016/S1473-3099(10)70143-2. Epub 2010 Aug 10.
3
Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010.
MMWR Morb Mortal Wkly Rep. 2010 Jun 25;59(24):750.
4
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
Antimicrob Agents Chemother. 2009 Dec;53(12):5046-54. doi: 10.1128/AAC.00774-09. Epub 2009 Sep 21.
5
Plasmid-mediated 16S rRNA methylases among extended-spectrum beta-lactamase-producing Enterobacteriaceae isolates.
Antimicrob Agents Chemother. 2008 Dec;52(12):4526-7. doi: 10.1128/AAC.00882-08. Epub 2008 Oct 6.
6
Identification of plasmids by PCR-based replicon typing.
J Microbiol Methods. 2005 Dec;63(3):219-28. doi: 10.1016/j.mimet.2005.03.018. Epub 2005 Jun 2.
7
Multidrug-resistant Shigella sonnei and Salmonella enterica Serotype typhimurium isolates producing CTX-M beta-lactamases as causes of community-acquired infection in France.
Clin Infect Dis. 2005 Apr 1;40(7):1069-70. doi: 10.1086/428667.
8
Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.
Antimicrob Agents Chemother. 2005 Jan;49(1):71-6. doi: 10.1128/AAC.49.1.71-76.2005.
9
Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France.
Antimicrob Agents Chemother. 2004 Apr;48(4):1249-55. doi: 10.1128/AAC.48.4.1249-1255.2004.
10
Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
Clin Infect Dis. 2002 Jul 15;35(2):140-5. doi: 10.1086/340742. Epub 2002 Jun 24.
Zotero 插件